LV10449B - New chroman and thiochroman derivatives - Google Patents

New chroman and thiochroman derivatives Download PDF

Info

Publication number
LV10449B
LV10449B LVP-93-819A LV930819A LV10449B LV 10449 B LV10449 B LV 10449B LV 930819 A LV930819 A LV 930819A LV 10449 B LV10449 B LV 10449B
Authority
LV
Latvia
Prior art keywords
alkyl
formula
alkenyl
compound
group
Prior art date
Application number
LVP-93-819A
Other languages
English (en)
Latvian (lv)
Other versions
LV10449A (lv
Inventor
Larsson Lars-Gunnar
Noreen Rolf
Renyi Lucy Anna
Ross Svante Bertil
Sohn Daniel Dungan
Svensson Bj Rn Eric
Thorberg Seth Olov
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LV10449A publication Critical patent/LV10449A/xx
Publication of LV10449B publication Critical patent/LV10449B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Liquid Crystal Substances (AREA)
  • Threshing Machine Elements (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Harvester Elements (AREA)
  • Medicinal Preparation (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
LVP-93-819A 1989-12-22 1993-06-30 New chroman and thiochroman derivatives LV10449B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8904361A SE8904361D0 (sv) 1989-12-22 1989-12-22 New chroman and thiochroman derivatives
PCT/SE1990/000863 WO1991009853A1 (en) 1989-12-22 1990-12-19 New chroman and thiochroman derivatives

Publications (2)

Publication Number Publication Date
LV10449A LV10449A (lv) 1995-02-20
LV10449B true LV10449B (en) 1995-10-20

Family

ID=20377869

Family Applications (2)

Application Number Title Priority Date Filing Date
LVP-93-819A LV10449B (en) 1989-12-22 1993-06-30 New chroman and thiochroman derivatives
LVP-97-111A LV11894B (en) 1989-12-22 1997-06-05 Jauni hromána un tiohromána atvasinájumi

Family Applications After (1)

Application Number Title Priority Date Filing Date
LVP-97-111A LV11894B (en) 1989-12-22 1997-06-05 Jauni hromána un tiohromána atvasinájumi

Country Status (42)

Country Link
EP (1) EP0460169B1 (da)
JP (1) JP2879972B2 (da)
KR (1) KR0178991B1 (da)
CN (1) CN1037438C (da)
AT (1) ATE138918T1 (da)
AU (1) AU641204B2 (da)
CA (1) CA2047237C (da)
CY (1) CY1991A (da)
CZ (1) CZ283630B6 (da)
DE (1) DE69027311T2 (da)
DK (1) DK0460169T3 (da)
DZ (1) DZ1469A1 (da)
EG (1) EG19749A (da)
ES (1) ES2087993T3 (da)
FI (1) FI102177B (da)
GR (1) GR3020497T3 (da)
HK (1) HK55897A (da)
HR (1) HRP920851B1 (da)
HU (1) HU211860A9 (da)
ID (1) ID945B (da)
IE (1) IE80753B1 (da)
IL (1) IL96712A (da)
IS (1) IS1665B (da)
LT (1) LT3967B (da)
LV (2) LV10449B (da)
MX (1) MX23889A (da)
NO (1) NO180336C (da)
NZ (1) NZ236407A (da)
PH (1) PH30797A (da)
PL (3) PL164609B1 (da)
PT (1) PT96304B (da)
RU (1) RU2092483C1 (da)
SA (1) SA90110186B1 (da)
SE (1) SE8904361D0 (da)
SG (1) SG48043A1 (da)
SI (1) SI9012429B (da)
SK (1) SK280261B6 (da)
TW (1) TW221056B (da)
UA (1) UA34416C2 (da)
WO (1) WO1991009853A1 (da)
YU (2) YU47936B (da)
ZA (1) ZA909708B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
CA2048846A1 (en) * 1990-08-15 1992-02-16 Craig Steven Hoechstetter Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and aminothiochromanes
NZ241495A (en) * 1991-02-08 1994-10-26 Lilly Co Eli 2-amino-1,2,3,4-tetrahydronaphthalene and 3-aminochromane derivative, preparation and pharmaceutical compositions thereof
HRP920935A2 (en) * 1991-10-08 1995-08-31 Astra Ab New therapeutically active compound
SE9103745D0 (sv) * 1991-12-18 1991-12-18 Wikstroem Haakan Aryl-triflates and related compounds
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5434174A (en) * 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
SE9301732D0 (sv) * 1993-05-18 1993-05-18 Haakan Wilhelm Wikstroem New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins
SE9703378D0 (sv) * 1997-09-18 1997-09-18 Astra Ab New compounds
SE9703377D0 (sv) * 1997-09-18 1997-09-18 Astra Ab New compounds
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
NZ526699A (en) * 2001-01-16 2005-03-24 Astrazeneca Ab 8-amino derivatives and their use in treating migraine
KR100864356B1 (ko) 2001-01-16 2008-10-17 아스트라제네카 아베 치료용 헤테로시클릭 화합물
KR20030070916A (ko) 2001-01-16 2003-09-02 아스트라제네카 아베 치료용 크로몬 화합물
ATE424825T1 (de) 2001-07-20 2009-03-15 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
US7125904B2 (en) 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
SE0301796D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use II
SE0301795D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use I
WO2008080120A2 (en) * 2006-12-22 2008-07-03 Wyeth 3-amino chromane derivatives
SA08290245B1 (ar) * 2007-04-23 2012-02-12 استرازينيكا ايه بي مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
CN101712672B (zh) * 2008-10-06 2013-02-06 中国中医科学院中药研究所 一种治疗心脑血管系统疾病新化合物及其制备方法、用途
DE102010041948A1 (de) 2010-10-04 2012-04-05 Mahle International Gmbh Filtereinrichtung
GB201316410D0 (en) 2013-09-13 2013-10-30 Bial Portela & Ca Sa Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222996B1 (de) * 1985-09-03 1991-05-22 Ciba-Geigy Ag 3-Amino-dihydro-[1]-benzopyrane und Benzothiopyrane
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
SE8605504D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel chroman derivatives
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53

Also Published As

Publication number Publication date
NO180336C (no) 1997-04-02
ZA909708B (en) 1991-08-28
FI913943A0 (fi) 1991-08-21
DE69027311T2 (de) 1996-10-24
HK55897A (en) 1997-05-09
YU242990A (sh) 1993-10-20
TW221056B (da) 1994-02-11
SG48043A1 (en) 1998-04-17
PL293065A1 (en) 1992-08-10
KR920701193A (ko) 1992-08-11
IS1665B (is) 1997-07-04
AU6977091A (en) 1991-07-24
CA2047237A1 (en) 1991-06-23
NO913273D0 (no) 1991-08-21
PT96304B (pt) 1998-09-30
CA2047237C (en) 2003-02-11
PL164609B1 (en) 1994-08-31
SA90110186B1 (ar) 2001-11-11
SI9012429A (en) 1997-12-31
UA34416C2 (uk) 2001-03-15
SK657890A3 (en) 1999-10-08
EP0460169A1 (en) 1991-12-11
JP2879972B2 (ja) 1999-04-05
CZ283630B6 (cs) 1998-05-13
EG19749A (en) 1996-01-31
YU47936B (sh) 1996-05-20
PH30797A (en) 1997-10-17
DZ1469A1 (fr) 2004-09-13
DE69027311D1 (en) 1996-07-11
LV10449A (lv) 1995-02-20
NO180336B (no) 1996-12-23
KR0178991B1 (ko) 1999-03-20
YU47923B (sh) 1996-05-20
SK280261B6 (sk) 1999-10-08
LTIP1730A (en) 1995-08-25
HU211860A9 (en) 1995-12-28
CZ657890A3 (cs) 1998-02-18
LV11894A (lv) 1997-12-20
JPH04503682A (ja) 1992-07-02
NZ236407A (en) 1993-08-26
WO1991009853A1 (en) 1991-07-11
AU641204B2 (en) 1993-09-16
IS3662A7 (is) 1991-06-23
IE904535A1 (en) 1991-07-03
FI102177B1 (fi) 1998-10-30
MX23889A (es) 1993-10-01
GR3020497T3 (en) 1996-10-31
SI9012429B (sl) 1998-10-31
NO913273L (no) 1991-10-08
ID945B (id) 1996-09-20
HRP920851A2 (en) 1995-10-31
YU72191A (sh) 1995-01-31
LT3967B (en) 1996-05-27
CN1037438C (zh) 1998-02-18
RU2092483C1 (ru) 1997-10-10
LV11894B (en) 1998-05-20
ES2087993T3 (es) 1996-08-01
IL96712A (en) 1995-08-31
ATE138918T1 (de) 1996-06-15
CN1052669A (zh) 1991-07-03
DK0460169T3 (da) 1996-09-23
PL164608B1 (pl) 1994-08-31
PL293066A1 (en) 1992-08-10
PT96304A (pt) 1991-09-30
IL96712A0 (en) 1991-09-16
PL164592B1 (pl) 1994-08-31
CY1991A (en) 1997-09-05
EP0460169B1 (en) 1996-06-05
HRP920851B1 (en) 2000-02-29
FI102177B (fi) 1998-10-30
SE8904361D0 (sv) 1989-12-22
IE80753B1 (en) 1999-01-13

Similar Documents

Publication Publication Date Title
LV10449B (en) New chroman and thiochroman derivatives
US5650524A (en) Process for preparing (R)-3-amino-5-methoxychroman
JP4395076B2 (ja) 三環式ステロイドホルモン核内受容体モジュレーター
KR20080011677A (ko) 신규 ｍｃｈｒ1 길항제 및 그의 ｍｃｈｒ1 매개된 상태 및장애의 치료를 위한 용도
KR100193981B1 (ko) 신규한 8-치환-2-아미노테트랄린
US4540691A (en) Dopamine agonists and use thereof
DK165691B (da) Tricykliske aminer afledt af 2,3,5,6,7,8-hexahydronaphtho(2,3-b)furan, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
EP1534276A2 (en) Non-nucleoside reverse transcriptase inhibitors
PL171013B1 (pl) Sposób wytwarzania nowego 3-(N-izopropylo-N-n-propyloamino)-5-(N-izopropylo)karbamoilochromanu PL PL PL PL PL